548 related articles for article (PubMed ID: 26802509)
1. Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases.
Khairallah MI; Kassem LA; Yassin NA; Gamal el Din MA; Zekri M; Attia M
Brain Res Bull; 2016 Mar; 121():148-57. PubMed ID: 26802509
[TBL] [Abstract][Full Text] [Related]
2. The hematopoietic growth factor "erythropoietin" enhances the therapeutic effect of mesenchymal stem cells in Alzheimer's disease.
Khairallah MI; Kassem LA; Yassin NA; El Din MA; Zekri M; Attia M
Pak J Biol Sci; 2014 Jan; 17(1):9-21. PubMed ID: 24783773
[TBL] [Abstract][Full Text] [Related]
3. TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration.
Ma L; Zhang H; Liu N; Wang PQ; Guo WZ; Fu Q; Jiao LB; Ma YQ; Mi WD
Brain Res Bull; 2016 Mar; 121():192-200. PubMed ID: 26851069
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia.
Wakida K; Shimazawa M; Hozumi I; Satoh M; Nagase H; Inuzuka T; Hara H
Neuroscience; 2007 Aug; 148(1):105-14. PubMed ID: 17624681
[TBL] [Abstract][Full Text] [Related]
5. Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.
Choi M; Lee Y; Cho SH
Chin J Integr Med; 2018 May; 24(5):378-384. PubMed ID: 28578486
[TBL] [Abstract][Full Text] [Related]
6. Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice.
Hou Y; Xie G; Liu X; Li G; Jia C; Xu J; Wang B
Psychopharmacology (Berl); 2016 Mar; 233(5):905-16. PubMed ID: 26645224
[TBL] [Abstract][Full Text] [Related]
7. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of glial fibrillary acidic protein and brain-derived neurotrophic factor expression in two transgenic mouse models of Alzheimer's disease.
Edwards SR; Khan N; Coulson EJ; Smith MT
Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1740-1750. PubMed ID: 32542833
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of chronic caffeine intake on gene expression of brain derived neurotrophic factor signaling and the immunoreactivity of glial fibrillary acidic protein and Ki-67 in Alzheimer's disease.
Ghoneim FM; Khalaf HA; Elsamanoudy AZ; Abo El-Khair SM; Helaly AM; Mahmoud el-HM; Elshafey SH
Int J Clin Exp Pathol; 2015; 8(7):7710-28. PubMed ID: 26339337
[TBL] [Abstract][Full Text] [Related]
10. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
12. Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology.
Liu S; Fan M; Xu JX; Yang LJ; Qi CC; Xia QR; Ge JF
J Neuroinflammation; 2022 Feb; 19(1):35. PubMed ID: 35130907
[TBL] [Abstract][Full Text] [Related]
13. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
14. 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation.
Zhang F; Zhang JG; Yang W; Xu P; Xiao YL; Zhang HT
Biomed Pharmacother; 2018 Nov; 107():1523-1529. PubMed ID: 30257370
[TBL] [Abstract][Full Text] [Related]
15. Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.
Ali MR; Abo-Youssef AM; Messiha BA; Khattab MM
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):637-56. PubMed ID: 27026404
[TBL] [Abstract][Full Text] [Related]
16. Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice.
Zhang XY; Cao JB; Zhang LM; Li YF; Mi WD
J Neuroinflammation; 2015 Feb; 12():20. PubMed ID: 25644393
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic benefit of a combined strategy using erythropoietin and endothelial progenitor cells after transient focal cerebral ischemia in rats.
Pellegrini L; Bennis Y; Guillet B; Velly L; Garrigue P; Sabatier F; Dignat-George F; Bruder N; Pisano P
Neurol Res; 2013 Nov; 35(9):937-47. PubMed ID: 23816235
[TBL] [Abstract][Full Text] [Related]
18. Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms.
Sadraie S; Kiasalari Z; Razavian M; Azimi S; Sedighnejad L; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
Metab Brain Dis; 2019 Feb; 34(1):245-255. PubMed ID: 30456649
[TBL] [Abstract][Full Text] [Related]
19. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model.
Lee ST; Chu K; Jung KH; Kim JH; Huh JY; Yoon H; Park DK; Lim JY; Kim JM; Jeon D; Ryu H; Lee SK; Kim M; Roh JK
Ann Neurol; 2012 Aug; 72(2):269-77. PubMed ID: 22926857
[TBL] [Abstract][Full Text] [Related]
20. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
